AAAAAA
Results:
1-25
|
Results: 25
Authors:
LEE JS
PISTERS KMW
KOMAKI R
GLISSON BS
PEREZSOLER R
KHURI FR
DELCLOS ME
FOSSELLA FV
Citation: Js. Lee et al., THE ROLE OF PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS A PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER/, Annals of oncology, 9, 1998, pp. 660-660
Authors:
HASKELL CM
MENDOZA E
PISTERS KMW
FOSSELLA FV
FIGLIN RA
Citation: Cm. Haskell et al., PHASE-II STUDY OF INTRAVENOUS ADENOSINE 5'-TRIPHOSPHATE IN PATIENTS WITH PREVIOUSLY UNTREATED STAGE IIIB AND STAGE-IV NONSMALL CELL LUNG-CANCER, Investigational new drugs, 16(1), 1998, pp. 81-85
Authors:
SHIN DM
WALSH GL
KOMAKI R
PUTNAM JB
NESBITT J
RO JY
SHIN HJC
KI KH
WIMBERLEY A
PISTERS KMW
SCHRUMP D
GREGURICH MA
COX JD
ROTH JA
HONG WK
Citation: Dm. Shin et al., A MULTIDISCIPLINARY APPROACH TO THERAPY FOR UNRESECTABLE MALIGNANT THYMOMA, Annals of internal medicine, 129(2), 1998, pp. 100-104
Authors:
MILLER VA
RIGAS JR
TONG WP
REID JR
PISTERS KMW
GRANT SC
HEELAN RT
KRIS MG
Citation: Va. Miller et al., PHASE-II TRIAL OF CHLOROQUINOXALINE SULFONAMIDE (CQS) IN PATIENTS WITH STAGE-III AND STAGE-IV NON-SMALL-CELL LUNG-CANCER, Cancer chemotherapy and pharmacology, 40(5), 1997, pp. 415-418
Authors:
PISTERS KMW
KRIS MG
BUNN PA
JOHNSON DH
RUCKDESCHEL JC
CROWLEY JJ
GINSBERG RJ
Citation: Kmw. Pisters et al., INDUCTION PACLITAXEL CARBOPLATIN IN EARLY-STAGE NONSMALL CELL LUNG-CANCER/, Seminars in oncology, 24(4), 1997, pp. 41-44
Authors:
LEE JS
PISTERS KMW
KOMAKI R
GLISSON BS
KHURI FR
SCHEA R
FOSSELLA FV
Citation: Js. Lee et al., PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT/, Seminars in oncology, 24(4), 1997, pp. 52-55
Authors:
ROTH JA
NGUYEN D
LAWRENCE DD
KEMP BL
CARRASCO CH
FERSON DZ
HONG WK
KOMAKI R
LEE JJ
NESBITT JC
PISTERS KMW
PUTNAM JB
SCHEA R
SHIN DM
WALSH GL
DOLORMENTE MM
HAN CI
MARTIN FD
YEN N
XU K
STEPHENS LC
MCDONNELL TJ
MUKHOPADHYAY T
CAI D
Citation: Ja. Roth et al., RETROVIRUS-MEDIATED WILD-TYPE P53 GENE-TRANSFER TO TUMORS OF PATIENTSWITH LUNG-CANCER, Nature medicine, 2(9), 1996, pp. 985-991
Authors:
PISTERS KMW
TYSON LB
TONG W
FLEISHER M
MILLER VA
GRANT SC
PFISTER DG
RIGAS JR
DENSMORE CL
KROL G
HEELAN RT
SIROTNAK FM
BERTINO JR
KRIS MG
Citation: Kmw. Pisters et al., HIGH-DOSE EDATREXATE WITH ORAL LEUCOVORIN RESCUE - A PHASE-I AND CLINICAL PHARMACOLOGICAL STUDY IN ADULTS WITH ADVANCED CANCER, Clinical cancer research, 2(11), 1996, pp. 1819-1824
Authors:
MILLER VA
RIGAS JR
PISTERS KMW
GRANT SC
PFISTER DG
HEELAN RT
KRIS MG
Citation: Va. Miller et al., IFOSAMIDE PLUS HIGH-DOSE CISPLATIN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER PREVIOUSLY TREATED WITH CHEMOTHERAPY (VOL 18, PG 303, 1995), American journal of clinical oncology, 19(6), 1996, pp. 637-637
Authors:
ALBERTI W
ANDERSON G
BARTOLUCCI A
BELL D
VILLALBA JB
BRODIN O
CARDIELLO C
CARTEI F
CARTEI G
CELLERINO R
CHASTANG C
CORMIER Y
COX JD
CRINO L
CROWLEY J
DAUTZENBERG B
DEPIERRE A
DIETEMANN A
DILLMAN RO
DOI O
FELD R
FIGLIN R
GANZ PA
GREEN MR
GREGOR A
HELLE PA
HERNDON JE
HITOMI S
HOST H
IMAIZUMI M
JETT JR
JOHNSON D
KAASA S
KIMURA H
KLASTERSKY J
KONDO H
KREISMAN H
KRIS MG
KUNISHIMA K
KUWAHARA O
LAD TE
LAING AH
MACBETH F
MASAOKA A
MATTSON K
MINATEL E
MIRA JG
MORI T
MOUNTAIN CF
NIEDERLE N
NIIRANEN A
NOU E
PAGE W
PATER J
PIANTADOSI S
PISTERS KMW
PYRHONEN S
QUOIX E
RAPP E
ROWELL NP
SAHMOUD T
SAWAMURA K
SCHALLIER DCC
SCOTT C
SIMPSON J
STAGG M
TERAMATSU T
TROVO MG
TSUCHIYA R
TUMMARELLO D
VANHOUTTE P
VANZANDWIJK N
VINCENT RG
WADA H
WHITE JE
WILLIAMS CJ
WOODS RL
YAMAGUCHI Y
ARRIAGADA R
CARTMELLDAVIES J
GIRLING DJ
LECHEVALIER T
MARSONI S
PARMAR MKB
PIGNON JP
REKACEWICZ C
SOUHAMI RL
STEWART LA
TARAYRE M
TINAZZI A
TONI V
Citation: W. Alberti et al., CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS, BMJ. British medical journal, 311(7010), 1995, pp. 899-909
Authors:
MILLER VA
RIGAS JR
PISTERS KMW
PFISTER DG
HEELAN RT
KRIS MG
Citation: Va. Miller et al., IFOSFAMIDE PLUS HIGH-DOSE CISPLATIN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER PREVIOUSLY TREATED WITH CHEMOTHERAPY, American journal of clinical oncology, 18(4), 1995, pp. 303-306
Authors:
KRIS MG
PISTERS KMW
GINSBERG RJ
RIGAS JR
MILLER VA
GRANT SC
GRALLA RJ
HEELAN RT
MARTINI N
Citation: Mg. Kris et al., EFFECTIVENESS AND TOXICITY OF PREOPERATIVE THERAPY IN STAGE IIIA NONSMALL CELL LUNG-CANCER INCLUDING THE MEMORIAL SLOAN-KETTERING EXPERIENCE WITH INDUCTION MVP IN PATIENTS WITH BULKY MEDIASTINAL LYMPH-NODE METASTASES (CLINICAL N2), Lung cancer, 12, 1995, pp. 47-57
Authors:
MILLER VA
RIGAS JR
GRANT SC
PISTERS KMW
KRIS MG
Citation: Va. Miller et al., NEW CHEMOTHERAPEUTIC-AGENTS FOR NONSMALL CELL LUNG-CANCER, Chest, 107(6), 1995, pp. 306-311
Authors:
CLERI LB
KRIS MG
TYSON LB
PISTERS KMW
CLARK RA
GRALLA RJ
Citation: Lb. Cleri et al., ORAL COMBINATION ANTIEMETICS IN PATIENTS WITH SMALL-CELL LUNG-CANCER RECEIVING CISPLATIN OR CYCLOPHOSPHAMIDE PLUS DOXORUBICIN, Cancer, 76(5), 1995, pp. 774-778
Authors:
MILLER VA
RIGAS JR
FRANCIS PA
GRANT SC
PISTERS KMW
VENKATRAMAN ES
WOOLLEY K
HEELAN RT
KRIS MG
Citation: Va. Miller et al., PHASE-II TRIAL OF A 75-MG M(2) DOSE OF DOCETAXEL WITH PREDNISONE PREMEDICATION FOR PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER/, Cancer, 75(4), 1995, pp. 968-972
Authors:
KRIS MG
PISTERS KMW
HINKLEY L
Citation: Mg. Kris et al., DELAYED EMESIS FOLLOWING ANTICANCER CHEMOTHERAPY, Supportive care in cancer, 2(5), 1994, pp. 297-300
Authors:
FRANCIS PA
RIGAS JR
KRIS MG
PISTERS KMW
ORAZEM JP
WOOLLEY KJ
HEELAN RT
Citation: Pa. Francis et al., PHASE-II TRIAL OF DOCETAXEL IN PATIENTS WITH STAGE-III AND STAGE-IV NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 12(6), 1994, pp. 1232-1237
Authors:
TYSON LB
KRIS MG
BALTZER L
PISTERS KMW
RIGAS JR
CLARK RA
Citation: Lb. Tyson et al., RANDOMIZED PHASE-II TRIAL COMPARING 2 VERSUS 3 DOSES OF ONDANSETRON WHEN USED IN COMBINATION WITH DEXAMETHASONE IN PATIENTS RECEIVING CISPLATIN GREATER-THAN-OR-EQUAL-TO-100MG M(2)/, American journal of clinical oncology, 17(3), 1994, pp. 269-272
Authors:
PISTERS KMW
KRIS MG
GRALLA RJ
HILARIS B
MCCORMACK PM
BAINS MS
MARTINI N
Citation: Kmw. Pisters et al., RANDOMIZED TRIAL COMPARING POSTOPERATIVE CHEMOTHERAPY WITH VINDESINE AND CISPLATIN PLUS THORACIC IRRADIATION WITH IRRADIATION ALONE IN STAGE-III (N2) NONSMALL CELL LUNG-CANCER, Journal of surgical oncology, 56(4), 1994, pp. 236-241
Authors:
BALTZER L
KRIS MG
TYSON LB
RIGAS JR
PISTERS KMW
Citation: L. Baltzer et al., THE ADDITION OF ONDANSETRON TO THE COMBINATION OF METOCLOPRAMIDE, DEXAMETHASONE, AND LORAZEPAM DID NOT IMPROVE VOMITING PREVENTION IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN, Cancer, 73(3), 1994, pp. 720-723
Authors:
POTANOVICH LM
PISTERS KMW
KRIS MG
TYSON LB
CLARK RA
BALTZER L
GRALLA RJ
Citation: Lm. Potanovich et al., MIDAZOLAM IN PATIENTS RECEIVING ANTICANCER CHEMOTHERAPY AND ANTIEMETICS, Journal of pain and symptom management, 8(8), 1993, pp. 519-524
Authors:
PISTERS KMW
KRIS MG
GRALLA RJ
ZAMAN MB
HEELAN RT
MARTINI N
Citation: Kmw. Pisters et al., PATHOLOGICAL COMPLETE RESPONSE IN ADVANCED NON-SMALL-CELL LUNG-CANCERFOLLOWING PREOPERATIVE CHEMOTHERAPY - IMPLICATIONS FOR THE DESIGN OF FUTURE NON-SMALL-CELL LUNG-CANCER COMBINED-MODALITY TRIALS, Journal of clinical oncology, 11(9), 1993, pp. 1757-1762
Authors:
BALTZER L
KRIS MG
TYSON LB
RIGAS JR
VREELAND F
PISTERS KMW
Citation: L. Baltzer et al., DOSE-RANGING ANTIEMETIC EVALUATION OF THE SEROTONIN ANTAGONIST RG-12915 IN PATIENTS RECEIVING ANTICANCER CHEMOTHERAPY, Cancer, 72(9), 1993, pp. 2695-2699
Authors:
KRIS MG
BALTZER L
PISTERS KMW
TYSON LB
Citation: Mg. Kris et al., ENHANCING THE EFFECTIVENESS OF THE SPECIFIC SEROTONIN ANTAGONISTS - COMBINATION ANTIEMETIC THERAPY WITH DEXAMETHASONE, Cancer, 72(11), 1993, pp. 3436-3442
Authors:
MARTINI N
KRIS MG
FLEHINGER BJ
GRALLA RJ
BAINS MS
BURT ME
HEELAN R
MCCORMACK PM
PISTERS KMW
RIGAS JR
RUSCH VW
GINSBERG RJ
Citation: N. Martini et al., PREOPERATIVE CHEMOTHERAPY FOR STAGE IIIA (N2) LUNG-CANCER - THE SLOAN-KETTERING EXPERIENCE WITH 136 PATIENTS, The Annals of thoracic surgery, 55(6), 1993, pp. 1365-1374
Risultati:
1-25
|